Donna p ankerst (5 risultati)
Lingua: Inglese
Editore: Humana, 2014
Serie: Current Clinical Urology, Libro 19 di 59. Libro 19 di 59 - Current Clinical Urology
- Brossura
Da: Devils in the Detail Ltd, Oxford, Regno UnitoDevils in the Detail Ltd
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Molto buono
EUR 13,29
EUR 18,75 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Condizione: Very Good. Picture Shown is For Illustration Purposes Only, Please See Below For Further DetailsCONDITION ? VERY GOOD - PAPERBACKlight wear and scuff marks to cover, light grub to fore edges, pages in nice condition, shipped from the UK.
Lingua: Inglese
Editore: Humana, 2009
Serie: Current Clinical Urology, Libro 19 di 59. Libro 19 di 59 - Current Clinical Urology
- Rilegato
Da: Basi6 International, Irving, TX, U.S.A.Basi6 International
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 84,84
Spedizione gratuitaSpedito in U.S.A.Quantità: 8 disponibili
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Prostate Cancer Screening. Second edition
Ankerst, Donna P., Catherine M. Tangen, and Ian M. Thompson Jr., Eds.
Lingua: Inglese
Editore: Humana Press, New York, 2009
Serie: Current Clinical Urology, Libro 19 di 59. Libro 19 di 59 - Current Clinical Urology
- Rilegato
Da: Research Ink, Takoma Park, MD, U.S.A.Research Ink
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Molto buono
EUR 90,48
EUR 3,51 spedizioneSpedito in U.S.A.Quantità: 1 disponibili
Hardback. Condizione: Very Good. xvi + 397 pp. Current Clinical Urology. Rubber-stamped on front free endpaper. book.
Lingua: Inglese
Editore: SP SPRINGER, 2009
Serie: Current Clinical Urology, Libro 19 di 59. Libro 19 di 59 - Current Clinical Urology
- Rilegato
- Edizione Internazionale
Da: UK BOOKS STORE, London, LONDO, Regno UnitoUK BOOKS STORE
Contatta il venditoreVenditore con 5 stelleEdizione InternazionaleCondizione: Nuovo
EUR 106,19
EUR 3,64 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Condizione: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if t…he Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Lingua: Inglese
Editore: London, Humana Press, 2009
Serie: Current Clinical Urology, Libro 19 di 59. Libro 19 di 59 - Current Clinical Urology
- Rilegato
- Prima edizione
Da: CSG Onlinebuch GMBH, Darmstadt, GermaniaCSG Onlinebuch GMBH
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Come nuovo
EUR 76,42
EUR 95,00 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
hard bound. Condizione: Wie neu. Gebraucht - Wie neu -More than one in six men will develop prostate cancer in their lifetime. In recent years there has been an explosion of information regarding PSA screening and biomarkers for the disease. In Prostate Cancer Screening, Second Edition, the world's leading experts on prostate ca…ncer detection update the first edition with the latest findings. The book incorporates a series of thoughtful and cutting-edge works from the world's experts in prostate cancer screening, ranging from the current status quo of prostate cancer screening across the globe to consensus on optimal utilization of the traditional PSA and DRE tests, to cutting-edge research in new biomarkers, biomeasures, and extended risk algorithms for prostate cancer. An additional chapter covers family-based linkage analysis as well as possible pitfalls in prostate cancer biomarker evaluation studies. Timely and authoritative, Prostate Cancer Screening, Second Edition, is an essential text for urologists, oncologists and family physicians, as well as researchers in the biomarker industry who seek methods to better develop and support markers and measures of prostate cancer.
